Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Amrize Q3 EPS $0.98 Misses $1.00 Estimate, Sales $3.675B Beat $3.454B Estimate

Author: Benzinga Newsdesk | October 28, 2025 03:16pm
Amrize (NYSE:AMRZ) reported quarterly earnings of $0.98 per share which missed the analyst consensus estimate of $1.00 by 2 percent. This is a 2 percent decrease over earnings of $1.00 per share from the same period last year. The company reported quarterly sales of $3.675 billion which beat the analyst consensus estimate of $3.454 billion by 6.40 percent. This is a 6.65 percent increase over sales of $3.446 billion the same period last year.

Posted In: AMRZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist